Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMEDNYSE:CHENASDAQ:LHCGNYSE:SGFY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMEDAmedisys$95.42+0.1%$93.04$82.15▼$99.97$3.13B0.96415,048 shs393,384 shsCHEChemed$569.50-0.1%$588.76$512.12▼$623.61$8.33B0.59100,393 shs101,483 shsLHCGLHC Group$169.81$166.14$115.32▼$169.84$5.27B0.43576,665 shsN/ASGFYSignify Health$30.49$29.85$10.70▼$30.50$7.21B0.372.48 million shsN/A12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMEDAmedisys0.00%-0.67%+4.21%+3.62%-0.15%CHEChemed0.00%-0.52%-3.13%+3.52%-0.41%LHCGLHC Group0.00%0.00%0.00%0.00%0.00%SGFYSignify Health0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMEDAmedisys2.9554 of 5 stars1.12.00.05.03.01.71.3CHEChemed4.6763 of 5 stars2.53.03.34.93.42.51.3LHCGLHC GroupN/AN/AN/AN/AN/AN/AN/AN/ASGFYSignify HealthN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMEDAmedisys 2.20Hold$100.755.59% UpsideCHEChemed 3.00Buy$674.0018.35% UpsideLHCGLHC Group 0.00N/AN/AN/ASGFYSignify Health 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CHE, LHCG, AMED, and SGFY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/28/2025CHEChemedRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$667.00 ➝ $674.004/16/2025AMEDAmedisysRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.003/14/2025CHEChemedRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$633.00 ➝ $667.003/4/2025AMEDAmedisysStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight ➝ Equal Weight$101.00 ➝ $101.002/12/2025AMEDAmedisysStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight ➝ Equal Weight$101.00 ➝ $101.00(Data available from 5/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMEDAmedisys$2.37B1.32$6.45 per share14.80$34.31 per share2.78CHEChemed$2.49B3.35$25.42 per share22.40$73.55 per share7.74LHCGLHC Group$2.22B2.37$7.51 per share22.60$52.17 per share3.25SGFYSignify Health$805.50M8.95$0.58 per share52.27$3.47 per share8.79Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMEDAmedisys-$9.75M$2.7137.8719.711.783.57%12.20%6.74%7/23/2025 (Estimated)CHEChemed$272.51M$20.5328.7824.442.1512.69%27.86%19.12%7/23/2025 (Estimated)LHCGLHC Group$115.73M$2.0582.8335.2322.732.73%8.13%4.63%N/ASGFYSignify Health-$576.80M-$3.29N/AN/AN/A-75.40%-10.24%-5.86%N/ALatest CHE, LHCG, AMED, and SGFY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/23/2025Q1 2025AMEDAmedisys$1.13$1.25+$0.12$1.84$597.43 million$594.78 million4/23/2025Q1 2025CHEChemed$5.59$5.63+$0.04$4.86$641.78 million$646.94 million2/26/2025Q4 2024AMEDAmedisys$1.05$0.96-$0.09-$0.62$602.38 million$598.05 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMEDAmedisysN/AN/AN/AN/AN/ACHEChemed$2.000.35%+8.74%9.74%16 YearsLHCGLHC GroupN/AN/AN/AN/AN/ASGFYSignify HealthN/AN/AN/AN/AN/ALatest CHE, LHCG, AMED, and SGFY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/14/2025CHEChemedquarterly$0.500.36%2/24/20252/24/20253/14/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMEDAmedisys0.051.191.19CHEChemedN/A1.851.81LHCGLHC Group0.441.451.45SGFYSignify Health0.411.621.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMEDAmedisys94.36%CHEChemed95.85%LHCGLHC Group83.47%SGFYSignify Health89.99%Insider OwnershipCompanyInsider OwnershipAMEDAmedisys2.10%CHEChemed3.29%LHCGLHC Group4.80%SGFYSignify Health8.02%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMEDAmedisys20,00032.82 million32.07 millionOptionableCHEChemed14,20014.63 million14.55 millionOptionableLHCGLHC Group30,00031.03 million29.54 millionOptionableSGFYSignify Health2,200236.51 million217.54 millionOptionableCHE, LHCG, AMED, and SGFY HeadlinesRecent News About These CompaniesSignify Health — a CVS Company — Shares How to Detect Early Detection of Cognitive ImpairmentDecember 12, 2024 | koin.comSignify Heath is expanding its offerings and making more visits. Here's howNovember 27, 2024 | fiercehealthcare.comSignify Health talks about the importance of diabetes prevention and managementNovember 25, 2024 | yahoo.comAmid Company Turmoil, CVS Health’s New CEO Sees Signify Health As A Bright SpotNovember 6, 2024 | homehealthcarenews.comHow CVS' Signify is working with Oak Street to grow in-home careNovember 5, 2024 | modernhealthcare.comFlying in Your Dreams? Sleep Experts Reveal Common Dream InterpretationsOctober 31, 2024 | cnet.comA promising schizophrenia drug showed mixed results. What does that mean for patients?October 31, 2024 | msn.comSignify's in-line results reassure investors, analysts predict strong Q4October 25, 2024 | reuters.comMarshfield Clinic Health System & Sanford Health are one step closer to a mergerOctober 23, 2024 | marshfieldnewsherald.comAll the News That’s Fit: Female health care access, medicines in space, and myths about soySeptember 25, 2024 | sandiegouniontribune.comTV20 Showcase: Health Management Tips from Signify HealthSeptember 25, 2024 | tv20detroit.comSignify Health | Morning BlendSeptember 20, 2024 | msn.comDignity Health appoints new head of Mercy General HospitalSeptember 19, 2024 | bizjournals.com‘Only The Beginning’: Signify Health Dives Into Condition-Focused Home VisitsSeptember 13, 2024 | homehealthcarenews.comPAGA Paraphrased – Stone v. Alameda Health SystemAugust 21, 2024 | jdsupra.comWhat exactly do we mean when we talk about ‘self-care’? Let’s look.August 20, 2024 | sgvtribune.com‘Significant step forward;’ Springfield High School unveils new health centerAugust 13, 2024 | msn.comGlobal Beta Rising Stars ETF (GBGR)July 21, 2024 | nz.finance.yahoo.comCHI Health St. Francis hosts Summer Safety SpectacularMay 23, 2024 | msn.comSignify Business Cash Card By Wells Fargo Review 2024May 23, 2024 | forbes.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Archer Aviation Unveils NYC Network Ahead of Key Earnings ReportBy Jeffrey Neal Johnson | April 18, 2025View Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Stocks Presenting Generational Buying OpportunitiesBy Chris Markoch | April 25, 2025View 3 Stocks Presenting Generational Buying OpportunitiesOccidental’s Hidden Gem: How OxyChem Could Boost ProfitsBy Jea Yu | April 29, 2025View Occidental’s Hidden Gem: How OxyChem Could Boost Profits5 Reasons the Rebound in Microchip Technology Stock Is RealBy Thomas Hughes | May 12, 2025View 5 Reasons the Rebound in Microchip Technology Stock Is RealCHE, LHCG, AMED, and SGFY Company DescriptionsAmedisys NASDAQ:AMED$95.42 +0.11 (+0.12%) Closing price 04:00 PM EasternExtended Trading$95.41 -0.01 (-0.01%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.Chemed NYSE:CHE$569.50 -0.72 (-0.13%) Closing price 03:59 PM EasternExtended Trading$567.73 -1.77 (-0.31%) As of 04:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.LHC Group NASDAQ:LHCGLHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical persoSignify Health NYSE:SGFYSignify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers under the Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. The company serves health plans, governments, employers, health systems, and physician groups. The company operates in Norwalk, Connecticut, New York, New York, Dallas, Texas, South Dakota, Deerfield, Florida, and Rapid City. Signify Health, Inc. was founded in 2017 and is headquartered in Dallas, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
